Sukma Skin Treatment   Report issue

For profit Phase 1 Phase 2
Founded: Makassar Indonesia (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2019
NCT04118296
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sukma Skin Treatment

Active Ingredients

Drugs in Phase 2 Trials (3)

clindamycin (cleocin) (1 trial)

dexamethasone (1 trial)

tretinoin (Retin-A) (1 trial)

Drugs in Phase 1 Trials (1)

mupirocin (bactroban) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4